Back أوكسيكودون Arabic اوکسی‌کدون AZB Оксикодон Bulgarian Oxicodona Catalan Oxykodon Czech Ocsycodon Welsh Oxycodon Danish Oxycodon German Οξυκωδόνη Greek Oksikodono Esperanto

Oxycodone

For the naturally occurring peptide hormone, see Oxytocin.

Oxycodone
Clinical data
Pronunciation/ɒksiˈkoʊdoʊn/
Trade namesRoxicodone, OxyContin, others
Other namesEukodal, eucodal; dihydrohydroxycodeinone, 7,8-dihydro-14-hydroxycodeinone, 6-deoxy-7,8-dihydro-14-hydroxy-3-O-methyl-6-oxomorphine[1]
AHFS/Drugs.comMonograph
MedlinePlusa682132
License data
Pregnancy
category
Dependence
liability		High[3]
Addiction
liability		High[4]
Routes of
administration		By mouth, sublingual, intramuscular, intravenous, intranasal, subcutaneous, transdermal, rectal, epidural[5]
Drug classOpioid
ATC code
Legal status
Legal status
Pharmacokinetic data
BioavailabilityBy mouth: 60–87%[8][9]
Protein binding45%[8]
MetabolismLiver: mainly CYP3A, and, to a much lesser extent, CYP2D6 (~5%);[8] 95% metabolized (i.e., 5% excreted unchanged)[11]
Metabolites• Noroxycodone (25%)[10][11]
• Noroxymorphone (15%, free and conjugated)[10][11]
• Oxymorphone (11%, conjugated)[10][11]
• Others (e.g., minor metabolites)[11]
Onset of actionIRTooltip Instant release: 10–30 minutes[9][11]
CRTooltip controlled release: 1 hour[12]
Elimination half-lifeIR: 2–3 hours[11][9]
CR: 4.5 hours[13]
Duration of actionIR: 3–6 hours[11]
CR: 10–12 hours[14]
ExcretionUrine (83%)[8]
Identifiers
  • (5R,9R,13S,14S)-4,5α-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.874 Edit this at Wikidata
Chemical and physical data
FormulaC18H21NO4
Molar mass315.369 g·mol−1
3D model (JSmol)
Melting point219 °C (426 °F)
Solubility in water166 (HCl)
  • O=C4[C@@H]5Oc1c2c(ccc1OC)C[C@H]3N(CC[C@]25[C@@]3(O)CC4)C
  • InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1 checkY
  • Key:BRUQQQPBMZOVGD-XFKAJCMBSA-N checkY
  (verify)

Oxycodone, sold under the brand name Roxicodone and OxyContin (which is the extended-release form) among others, is a semi-synthetic opioid used medically for the treatment of moderate to severe pain. It is highly addictive[15] and is a commonly abused drug.[16][17] It is usually taken by mouth, and is available in immediate-release and controlled-release formulations.[16] Onset of pain relief typically begins within fifteen minutes and lasts for up to six hours with the immediate-release formulation.[16] In the United Kingdom, it is available by injection.[18] Combination products are also available with paracetamol (acetaminophen), ibuprofen, naloxone, naltrexone, and aspirin.[16]

Common side effects include euphoria, constipation, nausea, vomiting, loss of appetite, drowsiness, dizziness, itching, dry mouth, and sweating.[16] Side effects may also include addiction and dependence, substance abuse, irritability, depression or mania, delirium, hallucinations, hypoventilation, gastroparesis, bradycardia, and hypotension.[16] Those allergic to codeine may also be allergic to oxycodone.[16] Use of oxycodone in early pregnancy appears relatively safe.[16] Opioid withdrawal may occur if rapidly stopped.[16] Oxycodone acts by activating the μ-opioid receptor.[19] When taken by mouth, it has roughly 1.5 times the effect of the equivalent amount of morphine.[20]

Oxycodone was originally produced from the opium poppy opiate alkaloid thebaine in 1916 in Germany. One year later, it was used medically for the first time in Germany in 1917.[21] It is on the World Health Organization's List of Essential Medicines.[22] It is available as a generic medication.[16] In 2022, it was the 60th most commonly prescribed medication in the United States, with more than 11 million prescriptions.[23][24] A number of abuse-deterrent formulations are available, such as in combination with naloxone or naltrexone.[17][25]

  1. ^ Cite error: The named reference MerckIndex was invoked but never defined (see the help page).
  2. ^ "Oxycodone Use During Pregnancy". Drugs.com. 14 October 2019. Archived from the original on 19 June 2020. Retrieved 12 April 2020.
  3. ^ Bonewit-West K, Hunt SA, Applegate E (2012). Today's Medical Assistant: Clinical and Administrative Procedures. Elsevier Health Sciences. p. 571. ISBN 978-1-4557-0150-6. Archived from the original on 6 October 2022. Retrieved 20 August 2019.
  4. ^ Bonewit-West K, Hunt SA, Applegate E (2012). Today's Medical Assistant: Clinical and Administrative Procedures. Elsevier Health Sciences. p. 571. ISBN 9781455701506. Archived from the original on 10 January 2023. Retrieved 20 August 2019.
  5. ^ Cite error: The named reference Kalso2005 was invoked but never defined (see the help page).
  6. ^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.
  7. ^ "Oxycontin- oxycodone hydrochloride tablet, film coated, extended release". DailyMed. 5 December 2024. Retrieved 7 February 2025.
  8. ^ a b c d "Roxicodone, OxyContin (oxycodone) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Archived from the original on 13 April 2014. Retrieved 8 April 2014.
  9. ^ a b c Cite error: The named reference ElliottSmith2016 was invoked but never defined (see the help page).
  10. ^ a b c "Roxicodone, OxyContin (oxycodone) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Archived from the original on 13 April 2014. Retrieved 4 January 2019.
  11. ^ a b c d e f g h Cite error: The named reference SmithPassik2008 was invoked but never defined (see the help page).
  12. ^ Yarbro CH, Wujcik D, Gobel BH (15 November 2010). Cancer Nursing: Principles and Practice. Jones & Bartlett Publishers. pp. 695–. ISBN 978-1-4496-1829-2.
  13. ^ Cite error: The named reference McPhersonPincus2016 was invoked but never defined (see the help page).
  14. ^ Cite error: The named reference sunshine1996 was invoked but never defined (see the help page).
  15. ^ Remillard D, Kaye AD, McAnally H (February 2019). "Oxycodone's Unparalleled Addictive Potential: Is it Time for a Moratorium?". Current Pain and Headache Reports. 23 (2): 15. doi:10.1007/s11916-019-0751-7. PMID 30820686. S2CID 73488265.
  16. ^ a b c d e f g h i j "Oxycodone Monograph for Professionals". Drugs.com. AHFS. Archived from the original on 28 December 2018. Retrieved 28 December 2018.
  17. ^ a b Pergolizzi JV, Taylor R, LeQuang JA, Raffa RB (2018). "Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product". Journal of Pain Research. 11: 301–311. doi:10.2147/JPR.S127602. PMC 5810535. PMID 29445297.
  18. ^ British national formulary : BNF 74 (74 ed.). British Medical Association. 2017. p. 442. ISBN 978-0-85711-298-9.
  19. ^ Talley NJ, Frankum B, Currow D (10 February 2015). Essentials of Internal Medicine 3e. Elsevier Health Sciences. pp. 491–. ISBN 978-0-7295-8081-6.
  20. ^ "Opioid Conversion / Equivalency Table". Stanford School of Medicine, Palliative Care. 20 April 2013. Archived from the original on 9 September 2020. Retrieved 27 October 2017.
  21. ^ Kalso E (May 2005). "Oxycodone". Journal of Pain and Symptom Management. 29 (5 Suppl): S47 – S56. doi:10.1016/j.jpainsymman.2005.01.010. PMID 15907646.
  22. ^ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
  23. ^ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
  24. ^ "Oxycodone Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.
  25. ^ Dart RC, Iwanicki JL, Dasgupta N, Cicero TJ, Schnoll SH (2017). "Do abuse deterrent opioid formulations work?". Journal of Opioid Management. 13 (6): 365–378. doi:10.5055/jom.2017.0415. PMID 29308584.

Rich TVX News Network Site

Rich TVX News Network Info

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search